Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Uri Galili

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Genes & Molecular Sequences

Carbohydrate Sequence

Concepts & Ideas

Molecular Sequence Data

Procedures

Anatomy

Physiology

Graft Rejection

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
10
Anaraki, Farvardin
9
Henion, TR
8
LaTemple, DC
8
Tanemura, Masahiro
6
Abdel-Motal, Ussama
6
Ogawa, Haruko
6
Chen, Zhao-chun
6
Yin, Deng-Ping
5
Wigglesworth, Kim
5
Gorelik, Elieser
5
Stone, Kevin
5
Walgenbach, Ann
4
Radic, Marko
3
Mohiuddin, Muhammad
3
Shen, Jikun

Sign-in to see all Coauthors

Publications

TOP 3
Abdel-Motal Ussama M; Wigglesworth Kim; Galili Uri
Intratumoral injection of alpha-gal glycolipids induces a protective anti-tumor T cell response which overcomes Treg activity.
Abdel-Motal Ussama M; Wigglesworth Kim; Galili Uri
Mechanism for increased immunogenicity of vaccines that form in vivo immune complexes with the natural anti-Gal antibody.
Abdel-Motal Ussama M; Guay Heath M; Wigglesworth Kim; Welsh Raymond M; Galili Uri
Immunogenicity of influenza virus vaccine is increased by anti-gal-mediated targeting to antigen-presenting cells.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Uri Galili (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Abdel-Motal Ussama M; Wigglesworth Kim; Galili Uri
Intratumoral injection of alpha-gal glycolipids induces a protective anti-tumor T cell response which overcomes Treg activity.
Cancer immunology, immunotherapy : CII 2009;58(10):1545-56.
2009: Abdel-Motal Ussama M; Wigglesworth Kim; Galili Uri
Mechanism for increased immunogenicity of vaccines that form in vivo immune complexes with the natural anti-Gal antibody.
Vaccine 2009;27(23):3072-82.
2007: Abdel-Motal Ussama M; Guay Heath M; Wigglesworth Kim; Welsh Raymond M; Galili Uri
Immunogenicity of influenza virus vaccine is increased by anti-gal-mediated targeting to antigen-presenting cells.
Journal of virology 2007;81(17):9131-41.
2007: Stone Kevin R; Walgenbach Ann W; Turek Thomas J; Somers Damon L; Wicomb Winston; Galili Uri
Anterior cruciate ligament reconstruction with a porcine xenograft: a serologic, histologic, and biomechanical study in primates.
Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association 2007;23(4):411-9.
2007: Galili Uri; Wigglesworth Kim; Abdel-Motal Ussama M
Intratumoral injection of alpha-gal glycolipids induces xenograft-like destruction and conversion of lesions into endogenous vaccines.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(7):4676-87.
2007: Stone Kevin R; Abdel-Motal Ussama M; Walgenbach Ann W; Turek Thomas J; Galili Uri
Replacement of human anterior cruciate ligaments with pig ligaments: a model for anti-non-gal antibody response in long-term xenotransplantation.
Transplantation 2007;83(2):211-9.
2006: Ogawa Haruko; Galili Uri
Profiling terminal N-acetyllactosamines of glycans on mammalian cells by an immuno-enzymatic assay.
Glycoconjugate journal 2006;23(9):663-74.
2006: Galili Uri
Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2006;35(1):45-58.
2006: Abdel-Motal Ussama; Wang Shixia; Lu Shan; Wigglesworth Kim; Galili Uri
Increased immunogenicity of human immunodeficiency virus gp120 engineered to express Galalpha1-3Galbeta1-4GlcNAc-R epitopes.
Journal of virology 2006;80(14):6943-51.
2005: Galili Uri
The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy.
Immunology and cell biology 2005;83(6):674-86.
2005: Deriy Lucy; Ogawa Haruko; Gao Guang-Ping; Galili Uri
In vivo targeting of vaccinating tumor cells to antigen-presenting cells by a gene therapy method with adenovirus containing the alpha1,3galactosyltransferase gene.
Cancer gene therapy 2005;12(6):528-39.
2005: Manches Olivier; Plumas Joel; Lui Gabrielle; Chaperot Laurence; Molens Jean-Paul; Sotto Jean-Jacques; Bensa Jean-Claude; Galili Uri
Anti-Gal-mediated targeting of human B lymphoma cells to antigen-presenting cells: a potential method for immunotherapy using autologous tumor cells.
Haematologica 2005;90(5):625-34.
2004: Galili Uri
Autologous tumor vaccines processed to express alpha-gal epitopes: a practical approach to immunotherapy in cancer.
Cancer immunology, immunotherapy : CII 2004;53(11):935-45.
2004: Galili Uri
Immune response, accommodation, and tolerance to transplantation carbohydrate antigens.
Transplantation 2004;78(8):1093-8.
2004: Ogawa Haruko; Mohiuddin Muhammad M; Yin Deng-Ping; Shen Jikun; Chong Anita S; Galili Uri
Mouse-heart grafts expressing an incompatible carbohydrate antigen. II. Transition from accommodation to tolerance.
Transplantation 2004;77(3):366-73.
2004: Ogawa H; Yin D-P; Galili U
Induction of immune tolerance to a transplantation carbohydrate antigen by gene therapy with autologous lymphocytes transduced with adenovirus containing the corresponding glycosyltransferase gene.
Gene therapy 2004;11(3):292-301.
2003: Galili Uri; Chen Zhao-chun; DeGeest Koen
Expression of alpha-gal epitopes on ovarian carcinoma membranes to be used as a novel autologous tumor vaccine.
Gynecologic oncology 2003;90(1):100-8.
2003: Mohiuddin Muhammad M; Ogawa Haruko; Yin Deng-Ping; Galili Uri
Tolerance induction to a mammalian blood group-like carbohydrate antigen by syngeneic lymphocytes expressing the antigen, II: tolerance induction on memory B cells.
Blood 2003;102(1):229-36.
2003: Ogawa Haruko; Yin Deng-Ping; Shen Jikun; Galili Uri
Tolerance induction to a mammalian blood group-like carbohydrate antigen by syngeneic lymphocytes expressing the antigen.
Blood 2003;101(6):2318-20.
2003: Mohiuddin Muhammad M; Ogawa Haruko; Yin Deng-Ping; Shen Jikun; Galili Uri
Antibody-mediated accommodation of heart grafts expressing an incompatible carbohydrate antigen.
Transplantation 2003;75(3):258-62.
2002: Tanemura Masahiro; Chong Anita S; DiSesa Verdi J; Galili Uri
Direct killing of xenograft cells by CD8+ T cells of discordant xenograft recipients.
Transplantation 2002;74(11):1587-95.
2002: Galili Uri; Ishida Hideki; Tanabe Kazunari; Toma Hiroshi
Anti-gal A/B, a novel anti-blood group antibody identified in recipients of abo-incompatible kidney allografts.
Transplantation 2002;74(11):1574-80.
2002: Tanemura Masahiro; Ogawa Haruko; Yin Deng-Ping; Chen Zhao-Chun; DiSesa Verdi J; Galili Uri
Elimination of anti-Gal B cells by alpha-Gal ricin1.
Transplantation 2002;73(12):1859-68.
2002: Deriy Lucy; Chen Zhao-chun; Gao Guang-Ping; Galili Uri
Expression of alpha-gal epitopes on HeLa cells transduced with adenovirus containing alpha1,3galactosyltransferase cDNA.
Glycobiology 2002;12(2):135-44.
2001: Galili U; Chen Z C; Manches O; Plumas J; Preisler H
Preparation of autologous leukemia and lymphoma vaccines expressing alpha-gal epitopes.
Journal of hematotherapy & stem cell research 2001;10(4):501-11.
2001: Galili U
The alpha-gal epitope (Gal alpha 1-3Gal beta 1-4GlcNAc-R) in xenotransplantation.
Biochimie 2001;83(7):557-63.
2001: Chen Z C; Tanemura M; Galili U
Synthesis of alpha-gal epitopes (Galalpha1-3Galbeta1-4GlcNAc-R) on human tumor cells by recombinant alpha1,3galactosyltransferase produced in Pichia pastoris.
Glycobiology 2001;11(7):577-86.
2001: Tanemura M; Yin D; DiSesa V J; Galili U
Preventing anti-Gal response in xenograft recipients by an alpha-Gal toxin.
Transplantation proceedings 2001;33(1-2):699-700.
2001: Galili U
The nature of elicited xenoantibodies.
Transplantation proceedings 2001;33(1-2):688-9.
2001: Gorelik E; Galili U; Raz A
On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis.
Cancer metastasis reviews 2001;20(3-4):245-77.
2000: Tanemura M; Yin D; Chong A; Galili U
Differential immune response to carbohydrate epitopes on allo- and xenografts: implications for accommodation.
Transplantation proceedings 2000;32(5):991-3.
2000: Tanemura M; Galili U
T cells interacting with the alpha-Gal epitope: studies in alpha1, 3Galactosyltransferase knock-out mice.
Transplantation proceedings 2000;32(5):921-3.
2000: Tanemura M; Galili U
Identification of B cells with receptors for alpha-Gal epitopes (Galalpha 1-3Galbeta1-4GlcNac-R) in xenograft recipients.
Transplantation proceedings 2000;32(5):857-8.
2000: Chen Z C; Galili U
Genes coding for anti-Gal in knock-out mice for the alpha1, 3Galactosyltransferase gene: analysis by hybridomas.
Transplantation proceedings 2000;32(5):846-7.
2000: Tanemura M; Galili U
Differential expression of alpha-Gal epitopes on pig and mouse organs.
Transplantation proceedings 2000;32(5):843.
2000: Chen Z C; Radic M Z; Galili U
Genes coding evolutionary novel anti-carbohydrate antibodies: studies on anti-Gal production in alpha 1,3galactosyltransferase knock out mice.
Molecular immunology 2000;37(8):455-66.
2000: Tanemura M; Yin D; Chong A S; Galili U
Differential immune responses to alpha-gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantation.
The Journal of clinical investigation 2000;105(3):301-10.
2000: Tanemura M; Maruyama S; Galili U
Differential expression of alpha-GAL epitopes (Galalpha1-3Galbeta1-4GlcNAc-R) on pig and mouse organs.
Transplantation 2000;69(1):187-90.
1999: LaTemple D C; Abrams J T; Zhang S Y; Galili U
Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
Cancer research 1999;59(14):3417-23.
1999: Galili U
Significance of anti-Gal IgG in chronic xenograft rejection.
Transplantation proceedings 1999;31(1-2):940-1.
1999: LaTemple D C; Galili U
Enhancement of autologous tumor vaccine immunogenicity by anti-Gal.
Sub-cellular biochemistry 1999;32():361-79.
1999: Galili U
Graves' disease as a model for anti-Gal involvement in autoimmune diseases.
Sub-cellular biochemistry 1999;32():339-60.
1999: Galili U; Wang L; LaTemple D C; Radic M Z
The natural anti-Gal antibody.
Sub-cellular biochemistry 1999;32():79-106.
1999: Henion T R; Galili U
Structure function studies of a New World monkey alpha 1,3galactosyltransferase. Analysis of alternative splicing and expression in baculovirus system.
Sub-cellular biochemistry 1999;32():49-77.
1999: Galili U
Evolution of alpha 1,3galactosyltransferase and of the alpha-Gal epitope.
Sub-cellular biochemistry 1999;32():1-23.
1998: LaTemple D C; Galili U
Adult and neonatal anti-Gal response in knock-out mice for alpha1,3galactosyltransferase.
Xenotransplantation 1998;5(3):191-6.
1998: Stone K R; Ayala G; Goldstein J; Hurst R; Walgenbach A; Galili U
Porcine cartilage transplants in the cynomolgus monkey. III. Transplantation of alpha-galactosidase-treated porcine cartilage.
Transplantation 1998;65(12):1577-83.
1998: Galili U; LaTemple D C; Radic M Z
A sensitive assay for measuring alpha-Gal epitope expression on cells by a monoclonal anti-Gal antibody.
Transplantation 1998;65(8):1129-32.
1997: Henion T R; Gerhard W; Anaraki F; Galili U
Synthesis of alpha-gal epitopes on influenza virus vaccines, by recombinant alpha 1,3galactosyltransferase, enables the formation of immune complexes with the natural anti-Gal antibody.
Vaccine 1997;15(11):1174-82.
1997: Shinkel T A; Chen C G; Salvaris E; Henion T R; Barlow H; Galili U; Pearse M J; d'Apice A J
Changes in cell surface glycosylation in alpha1,3-galactosyltransferase knockout and alpha1,2-fucosyltransferase transgenic mice.
Transplantation 1997;64(2):197-204.
1997: Wang L; Radic M Z; Siegel D; Chang T; Bracy J; Galili U
Cloning of anti-Gal Fabs from combinatorial phage display libraries: structural analysis and comparison of Fab expression in pComb3H and pComb8 phage.
Molecular immunology 1997;34(8-9):609-18.
1997: Galili U; LaTemple D C
Natural anti-Gal antibody as a universal augmenter of autologous tumor vaccine immunogenicity.
Immunology today 1997;18(6):281-5.
1997: Galili U; LaTemple D C; Walgenbach A W; Stone K R
Porcine and bovine cartilage transplants in cynomolgus monkey: II. Changes in anti-Gal response during chronic rejection.
Transplantation 1997;63(5):646-51.
1997: Stone K R; Walgenbach A W; Abrams J T; Nelson J; Gillett N; Galili U
Porcine and bovine cartilage transplants in cynomolgus monkey: I. A model for chronic xenograft rejection.
Transplantation 1997;63(5):640-5.
1997: Gorelik E; Xu F; Henion T; Anaraki F; Galili U
Reduction of metastatic properties of BL6 melanoma cells expressing terminal fucose(alpha)1-2-galactose after alpha1,2-fucosyltransferase cDNA transfection.
Cancer research 1997;57(2):332-6.
1996: Galili U; Matta K L
Inhibition of anti-Gal IgG binding to porcine endothelial cells by synthetic oligosaccharides.
Transplantation 1996;62(2):256-62.
1996: LaTemple D C; Henion T R; Anaraki F; Galili U
Synthesis of alpha-galactosyl epitopes by recombinant alpha1,3galactosyl transferase for opsonization of human tumor cell vaccines by anti-galactose.
Cancer research 1996;56(13):3069-74.
1996: Galili U; Repik P M; Anaraki F; Mozdzanowska K; Washko G; Gerhard W
Enhancement of antigen presentation of influenza virus hemagglutinin by the natural human anti-Gal antibody.
Vaccine 1996;14(4):321-8.
1995: Galili U; Anaraki F
alpha-galactosyl (Galalpha1-3Galbeta1-4GlcNAc-R) epitopes on human cells: synthesis of the epitope on human red cells by recombinant primate alpha1,3galactosyltransferase expressed in E.coli.
Glycobiology 1995;5(8):775-82.
1995: Gorelik E; Duty L; Anaraki F; Galili U
Alterations of cell surface carbohydrates and inhibition of metastatic property of murine melanomas by alpha 1,3 galactosyltransferase gene transfection.
Cancer research 1995;55(18):4168-73.
1995: Wang L; Radic M Z; Galili U
Human anti-Gal heavy chain genes. Preferential use of VH3 and the presence of somatic mutations.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(3):1276-85.
1995: Galili U; Gregory C R; Morris R E
Contribution of anti-Gal to primate and human IgG binding to porcine endothelial cells.
Transplantation 1995;60(2):210-3.
1995: Wang L; Anaraki F; Henion T R; Galili U
Variations in activity of the human natural anti-Gal antibody in young and elderly populations.
The journals of gerontology. Series A, Biological sciences and medical sciences 1995;50(4):M227-33.
1995: Galili U; Tibell A; Samuelsson B; Rydberg L; Groth C G
Increased anti-Gal activity in diabetic patients transplanted with fetal porcine islet cell clusters.
Transplantation 1995;59(11):1549-56.
1995: Hamadeh R M; Galili U; Zhou P; Griffiss J M
Anti-alpha-galactosyl immunoglobulin A (IgA), IgG, and IgM in human secretions.
Clinical and diagnostic laboratory immunology 1995;2(2):125-31.
1994: Winand R J; Devigne J W; Meurisse M; Galili U
Specific stimulation of Graves' disease thyrocytes by the natural anti-Gal antibody from normal and autologous serum.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(3):1386-95.
1994: Repik P M; Strizki J M; Galili U
Differential host-dependent expression of alpha-galactosyl epitopes on viral glycoproteins: a study of eastern equine encephalitis virus as a model.
The Journal of general virology 1994;75 ( Pt 5)():1177-81.
1994: Henion T R; Macher B A; Anaraki F; Galili U
Defining the minimal size of catalytically active primate alpha 1,3 galactosyltransferase: structure-function studies on the recombinant truncated enzyme.
Glycobiology 1994;4(2):193-201.
1993: Gorelik E; Kim M; Duty L; Henion T; Galili U
Control of metastatic properties of BL6 melanoma cells by H-2Kb gene: immunological and nonimmunological mechanisms.
Clinical & experimental metastasis 1993;11(6):439-52.
1993: Kim M; Rao M V; Tweardy D J; Prakash M; Galili U; Gorelik E
Lectin-induced apoptosis of tumour cells.
Glycobiology 1993;3(5):447-53.
1993: Winand R J; Anaraki F; Etienne-Decerf J; Galili U
Xenogeneic thyroid-stimulating hormone-like activity of the human natural anti-Gal antibody. Interaction of anti-Gal with porcine thyrocytes and with recombinant human thyroid-stimulating hormone receptors expressed on mouse cells.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(7):3923-34.
1993: Galili U; Anaraki F; Thall A; Hill-Black C; Radic M
One percent of human circulating B lymphocytes are capable of producing the natural anti-Gal antibody.
Blood 1993;82(8):2485-93.
1993: Galili U
Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody.
Springer seminars in immunopathology 1993;15(2-3):155-71.
1992: Heda G D; Henion T R; Galili U
A simple in vitro site directed mutagenesis of concatamerized cDNA by inverse polymerase chain reaction.
Nucleic acids research 1992;20(19):5241-2.
1992: Hamadeh R M; Jarvis G A; Galili U; Mandrell R E; Zhou P; Griffiss J M
Human natural anti-Gal IgG regulates alternative complement pathway activation on bacterial surfaces.
The Journal of clinical investigation 1992;89(4):1223-35.
1991: Galili U; Swanson K
Gene sequences suggest inactivation of alpha-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(16):7401-4.
1991: Thall A; Etienne-Decerf J; Winand R J; Galili U
The alpha-galactosyl epitope on mammalian thyroid cells.
Acta endocrinologica 1991;124(6):692-9.
1991: Sorette M P; Galili U; Clark M R
Comparison of serum anti-band 3 and anti-Gal antibody binding to density-separated human red blood cells.
Blood 1991;77(3):628-36.
1991: Thall A; Etienne-Decerf J; Winand R J; Galili U
The alpha-galactosyl epitope on human normal and autoimmune thyroid cells.
Autoimmunity 1991;10(2):81-7.
1990: Thall A; Galili U
Distribution of Gal alpha 1----3Gal beta 1----4GlcNAc residues on secreted mammalian glycoproteins (thyroglobulin, fibrinogen, and immunoglobulin G) as measured by a sensitive solid-phase radioimmunoassay.
Biochemistry 1990;29(16):3959-65.
1989: Galili U
Abnormal expression of alpha-galactosyl epitopes in man. A trigger for autoimmune processes?
Lancet 1989;2(8659):358-61.
1989: Galili U; Kobrin E; Macher B A; Shohet S B
Anti-Gal and human red cell aging.
Progress in clinical and biological research 1989;319():225-41; discussion 242-5.
1988: Galili U; Shohet S B; Kobrin E; Stults C L; Macher B A
Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells.
The Journal of biological chemistry 1988;263(33):17755-62.
1988: Galili U; Mandrell R E; Hamadeh R M; Shohet S B; Griffiss J M
Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora.
Infection and immunity 1988;56(7):1730-7.
1988: Galili U
The two antibody specificities within human anti-blood group B antibodies.
Transfusion medicine reviews 1988;2(2):112-21.
1988: Lane P A; Galili U; Iarocci T A; Shew R L; Mentzer W C
Cellular dehydration and immunoglobulin binding in senescent neonatal erythrocytes.
Pediatric research 1988;23(3):288-92.
1988: Galili U
Glucocorticoid-induced lysis of human leukemia cells.
Progress in clinical and biological research 1988;276():43-59.
1988: Galili U
The natural anti-Gal antibody, the B-like antigen, and human red cell aging.
Blood cells 1988;14(1):205-28.

Sign-in to see more